Alzheimer’s Blood Test Cutoffs: What an Intermediate Result Means

Learn what an intermediate Alzheimer's blood result means and what confirmatory test to discuss next.

An intermediate blood result means the test could neither confirm nor rule out amyloid plaques in the brain. Amyloid plaques are protein clumps linked to Alzheimer's disease. It is not a diagnosis and usually points to follow-up testing.

Blood tests measure markers such as p-tau217, a modified tau protein, often as a ratio with amyloid proteins. A cutoff is the score line that separates low from high likelihood. An intermediate range sits between two such lines.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Why do some tests have a middle range?

Some tests use two cutoffs instead of one. A 2024 Lund University study in primary and secondary care set the lower cutoff at 95% sensitivity and the upper cutoff at 95% specificity, labeling scores between them intermediate, according to the JAMA report. The original C2N PrecivityAD test used three bands. Mayo Clinic Laboratories reports scores of 0-35 meant low likelihood of plaques, 58-100 meant high likelihood, and 36-57 were intermediate and did not distinguish presence or absence, according to the Mayo Clinic Laboratories catalog.

This design reduces clear false calls. Scores far below the lower line are likely negative. Scores far above the upper line are likely positive. Scores near the middle stay uncertain.

What should happen after an intermediate result?

Expect a referral for confirmatory testing. That usually means amyloid PET brain imaging or spinal fluid testing for Alzheimer's markers. This is a defined next step, not a failed test.

A 2026 ADLM review estimates this pathway affects roughly 15%-30% of tested patients under three-range approaches, according to the ADLM review. Bring your test report, symptom timeline, and medication list to that visit. Ask these practical questions:.

  • Which confirmatory test fits my health and insurance?
  • How soon should it be scheduled?
  • Should other causes of memory change be checked first?

Do all blood tests use this gray zone?

No. Some newer tests use one line. The successor PrecivityAD2 test combines plasma amyloid and percent p-tau217 into an APS2 score of 0-100, with above 47.5 classed as high likelihood and below 47.5 as low likelihood of amyloid-PET positivity. A single cutoff gives a clearer yes-or-no answer.

It can still produce false positives and false negatives near the line. Borderline scores deserve careful review even when labeled low or high. The Alzheimer's Association guideline says blood tests with at least 90% sensitivity and 90% specificity may substitute for PET or spinal fluid testing in cognitively impaired specialty-clinic patients, according to Patient Care Online's summary. Tests that do not meet that bar still need confirmation.

Who are these tests meant for?

Cleared blood tests are meant only for adults who already have signs of thinking or memory decline. They are not approved for screening people without symptoms. Age rules differ by product.

Lumipulse targets age 55 and older, while PrecivityAD2 can apply as young as age 40. The Fujirebio Lumipulse ratio was cleared May 16, 2025 as the first blood-based test of its type to aid Alzheimer's diagnosis. Do not order one for general brain-health screening. A doctor first needs to document cognitive impairment and rule out other urgent causes.

Can other health problems shift the score?

Yes. Kidney disease and heart failure can raise blood marker levels. Dehydration, recent illness, and some medicines can also add noise. Ratio-based measures help control this problem.

Using p-tau217 in a ratio lowers the effect of other illness, but does not remove it. Tell the ordering doctor about kidney, heart, and liver conditions before testing. If you have unstable illness, ask whether to wait. A repeat blood draw after recovery may be cleaner than rushing to PET. Keep the same lab method if a repeat is planned.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.